日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.

潜伏性巨细胞病毒感染通过NKG2C+ NK细胞在健康人体内的积累增强抗肿瘤细胞毒性

Bigley A B, Rezvani K, Shah N, Sekine T, Balneger N, Pistillo M, Agha N, Kunz H, O'Connor D P, Bollard C M, Simpson R J

Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant

生成多种白血病抗原特异性T细胞以增强同种异体干细胞移植后的移植物抗白血病效应

Weber, G; Gerdemann, U; Caruana, I; Savoldo, B; Hensel, N F; Rabin, K R; Shpall, E J; Melenhorst, J J; Leen, A M; Barrett, A J; Bollard, C M

Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy

慢性肉芽肿病中针对曲霉病的强效T细胞反应:对免疫疗法的启示

Cruz, C R Y; Lam, S; Hanley, P J; Bear, A S; Langston, C; Cohen, A J; Liu, H; Martinez, C A; Krance, R A; Heslop, H E; Rooney, C M; Hanson, I C; Bollard, C M

Pediatric Hodgkin lymphoma: are we over-scanning our patients?

儿童霍奇金淋巴瘤:我们是否对患者进行了过度扫描?

Rathore, N; Eissa, H M; Margolin, J F; Liu, H; Wu, M F; Horton, T; Kamdar, K; Dreyer, Z; Steuber, P; Rabin, K R; Redell, M; Allen, C E; McClain, K L; Guillerman, R P; Bollard, C M

Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

通过序贯进行EBV(+)相关异基因造血干细胞移植,随后接受供者来源的EBV特异性细胞毒性T淋巴细胞免疫治疗,一名难治性EBV(+)水痘样T细胞淋巴瘤患儿获得长期缓解。

El-Mallawany, N K; Geller, L; Bollard, C M; Wistinghausen, B; Mussai, F; Wayne, A S; Alobeid, B; Cairo, M S

Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution

单中心造血干细胞移植作为青少年和青年霍奇金淋巴瘤挽救治疗的疗效

Shafer, J A; Heslop, H E; Brenner, M K; Carrum, G; Wu, M F; Liu, H; Ahmed, N; Gottschalk, S; Kamble, R; Leung, K S; Myers, G D; Bollard, C M; Krance, R A